Technology
Advisory
China, France
M&A Advisory
M&A Advisory Firm
Industry:
Technology
Location:
China, France
Year:
2018
Full Credential Description
Transgene SA. China, France. Announced Date 10/07/2018. Closed Date 20/08/2018. Transgene and Tasly Biopharmaceuticals conclude strategic agreements for the rights of Transgene’s virus-based immunotherapies TG6002 and TG1050 in Greater China. Industry: Transgene SA operates in the biotechnology industry, focusing on the development of immunotherapies for the treatment of cancer and infectious diseases.
Measurable Results
Undisclosed